{"status": "OK", "response": {"docs": [{"type_of_material": "Blog", "blog": [], "news_desk": null, "lead_paragraph": "Uwe E. Reinhardt is an economics professor at Princeton.", "headline": {"main": "The Uproar Over Mammography", "kicker": "Economix"}, "abstract": "An economist asks whether the new breast-exam guidelines were really about saving money.", "print_page": null, "word_count": 921, "_id": "4fd3983e8eb7c8105d8d252b", "snippet": "An economist asks whether the new breast-exam guidelines were really about saving money.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://economix.blogs.nytimes.com/2009/11/20/the-uproar-over-mammography/", "multimedia": [], "subsection_name": null, "keywords": [{"value": "News", "name": "type_of_material", "rank": "1"}], "byline": {"person": [{"firstname": "Uwe", "middlename": "E.", "lastname": "REINHARDT", "rank": 1, "role": "reported", "organization": ""}], "original": "By UWE E. REINHARDT"}, "document_type": "blogpost", "pub_date": "2009-11-20T07:49:23Z", "section_name": "Business Day"}, {"type_of_material": "News", "blog": [], "news_desk": "National", "lead_paragraph": "Senator Harry Reid scheduled the first crucial procedural vote on the major health care legislation for Saturday, after what is expected to be two marathon days of debate.", "headline": {"main": "Senate Health Care Bill Faces Crucial First Vote", "print_headline": "Senate Health Bill Covers Fewer Than House Version, but Would Cost Less"}, "abstract": null, "print_page": "24", "word_count": "961", "_id": "5458a8ed798810533a8de9b9", "snippet": "Senator Harry Reid scheduled the first crucial procedural vote on the major health care legislation for Saturday, after what is expected to be two marathon days of debate.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2009/11/20/health/policy/20health.html", "multimedia": [], "subsection_name": "Money & Policy", "keywords": [{"rank": "1", "is_major": "N", "value": "Health Insurance and Managed Care", "name": "subject"}, {"rank": "2", "is_major": "N", "value": "Reform and Reorganization", "name": "subject"}, {"rank": "3", "is_major": "N", "value": "Senate", "name": "organizations"}, {"rank": "4", "is_major": "N", "value": "Reid, Harry", "name": "persons"}], "byline": {"contributor": "Carl Hulse contributed reporting.", "person": [{"organization": "", "role": "reported", "firstname": "Robert", "rank": 1, "lastname": "PEAR"}], "original": "By ROBERT PEAR"}, "document_type": "article", "pub_date": "2009-11-20T00:00:00Z", "section_name": "Health"}, {"type_of_material": "News", "blog": [], "news_desk": "Science", "lead_paragraph": "An experimental treatment for glioblastoma suppresses a barrier to deliver a drug directly to brain tumors.", "headline": {"seo": "Breaching the Blood-Brain Barrier With Avastin to Fight Glioblastoma", "main": "Breaching a Barrier to Fight Brain Cancer", "sub": "Extending Life ;", "print_headline": "Breaching a Barrier to Fight Brain Cancer"}, "abstract": null, "print_page": "1", "word_count": "2102", "_id": "545877ea798810533a8de56b", "snippet": "An experimental treatment for glioblastoma suppresses a barrier to deliver a drug directly to brain tumors.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2009/11/17/health/17tumor.html", "multimedia": [{"width": 600, "url": "images/2009/11/17/science/17tumor-span/articleLarge.jpg", "height": 350, "subtype": "xlarge", "legacy": {"xlargewidth": "600", "xlarge": "images/2009/11/17/science/17tumor-span/articleLarge.jpg", "xlargeheight": "350"}, "type": "image"}, {"width": 75, "url": "images/2009/11/17/science/17tumor-span/thumbStandard.jpg", "height": 75, "subtype": "thumbnail", "legacy": {"thumbnailheight": "75", "thumbnail": "images/2009/11/17/science/17tumor-span/thumbStandard.jpg", "thumbnailwidth": "75"}, "type": "image"}], "subsection_name": null, "keywords": [{"rank": "1", "is_major": "N", "value": "Avastin (Drug)", "name": "subject"}, {"rank": "2", "is_major": "N", "value": "Tumors", "name": "subject"}, {"rank": "3", "is_major": "N", "value": "Brain", "name": "subject"}, {"rank": "4", "is_major": "N", "value": "Medicine and Health", "name": "subject"}, {"rank": "5", "is_major": "N", "value": "Chemotherapy", "name": "subject"}, {"rank": "6", "is_major": "N", "value": "Cancer", "name": "subject"}], "byline": {"person": [{"organization": "", "role": "reported", "firstname": "Denise", "rank": 1, "lastname": "GRADY"}], "original": "By DENISE GRADY"}, "document_type": "article", "pub_date": "2009-11-17T00:00:00Z", "section_name": "Health"}, {"type_of_material": "News", "blog": [], "news_desk": "Business", "lead_paragraph": "Critics say the industry is trying to establish a higher price base before Congress passes legislation that tries to curb drug spending in coming years.", "headline": {"seo": "Drug Makers Raising Prices Before Reform", "main": "Drug Makers Raise Prices in Face of Health Care Reform", "sub": "A Stance at Odds With Agreement to Shave $8 Billion a Year ;", "print_headline": "DRUG COMPANIES INCREASE PRICES IN FACE OF CHANGE"}, "abstract": null, "print_page": "1", "word_count": "1303", "_id": "54588192798810533a8de647", "snippet": "Critics say the industry is trying to establish a higher price base before Congress passes legislation that tries to curb drug spending in coming years.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2009/11/16/business/16drugprices.html", "multimedia": [{"width": 190, "url": "images/2009/11/16/business/16drugprices_graphic/thumbWide.jpg", "height": 126, "subtype": "wide", "legacy": {"wide": "images/2009/11/16/business/16drugprices_graphic/thumbWide.jpg", "wideheight": "126", "widewidth": "190"}, "type": "image"}, {"width": 75, "url": "images/2009/11/16/business/16drugprices_CA0/thumbStandard.jpg", "height": 75, "subtype": "thumbnail", "legacy": {"thumbnailheight": "75", "thumbnail": "images/2009/11/16/business/16drugprices_CA0/thumbStandard.jpg", "thumbnailwidth": "75"}, "type": "image"}], "subsection_name": null, "keywords": [{"rank": "1", "is_major": "N", "value": "Health Insurance and Managed Care", "name": "subject"}, {"rank": "2", "is_major": "N", "value": "Drugs (Pharmaceuticals)", "name": "subject"}, {"rank": "3", "is_major": "N", "value": "Reform and Reorganization", "name": "subject"}, {"rank": "4", "is_major": "N", "value": "Prices (Fares, Fees and Rates)", "name": "subject"}, {"rank": "5", "is_major": "N", "value": "Medicine and Health", "name": "subject"}, {"rank": "6", "is_major": "N", "value": "AARP", "name": "organizations"}, {"rank": "7", "is_major": "N", "value": "Merck & Company Inc", "name": "organizations"}], "byline": {"person": [{"organization": "", "role": "reported", "firstname": "Duff", "rank": 1, "lastname": "WILSON"}], "original": "By DUFF WILSON"}, "document_type": "article", "pub_date": "2009-11-16T00:00:00Z", "section_name": "Business Day"}], "meta": {"hits": 4, "offset": 0, "time": 39}}, "copyright": "Copyright (c) 2013 The New York Times Company.  All Rights Reserved."}